Form 4 for PRVA Privia Health Group, Inc.

Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001858398-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-12	2026-03-10+	PRVA	Mehrotra Parth	CEO, Dir	A - Grant	$0.00	+313.2K	635.9K	+97%	$0
	2026-03-12	2026-03-10	PRVA	Mehrotra Parth	CEO, Dir	S - Sale	$22.71	-21.1K	322.7K	-6%	-$479.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.01 par value per share	2026-03-10	A	A	141,342	$0.00	464,040	D	—	—	(F3) Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
2	Common	Common Stock, $0.01 par value per share	2026-03-11	A	A	171,904	$0.00	635,944	D	—	—	(F4) Vesting and distribution to reporting person of 141,948 shares underlying performance stock units that were granted on May 9, 2023, and 29,956 shares underlying performance stock units that were granted on July 1, 2023, in both cases for the performance period 2023-2025.
3	Common	Common Stock, $0.01 par value per share	2026-03-10	S	D	21,097	$22.71	322,698	D	—	—	(F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.27 to $23.23 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.